Did you buy Beekeeper's Naturals Kids Propolis Cough Syrup for your child? A new lawsuit claims the product makes illegal drug claims without FDA approval.

Christian Marquez of Riverside, California, filed a class action lawsuit on March 30, 2026, against Beekeeper's Naturals USA, alleging the company marketed its Kids Propolis Cough Syrup with unlawful health claims. The complaint, filed in the U.S. District Court for the Central District of California, claims the product is effectively an unapproved drug being sold to parents of children as young as 1 year old.

Marquez says he purchased the cough syrup approximately three to four times in 2025 from Clarks Nutrition and Target, trusting the label's promises that it could soothe coughs, support the immune system and help children recover. The lawsuit seeks to represent all U.S. residents who bought the product from Jan. 1, 2019 to the present.

Why the lawsuit calls it an "unapproved drug"

Under federal law, any product marketed to treat, cure or prevent disease is legally classified as a drug, which requires Food and Drug Administration approval before a company can sell it. The complaint claims Beekeeper's Naturals' marketing language crosses that line with phrases like "immune-supporting elixir," "soothes dry coughs" and "promotes recovery to help get your little ones back on their feet" when the company allegedly never sought or received FDA approval.

The suit's issue with propolis

Propolis, the resin-like substance bees produce to seal their hives, is central to the company's brand. The complaint claims the government cannot reliably standardize propolis for a commercial health product because its chemical makeup shifts depending on bee species, geography and plant life. That variability makes clinical research unreliable and safe dosing guidelines for young children impossible to establish, the lawsuit contends.

The complaint cites a Cleveland Clinic article quoting Dr. Robert Saper, who said there is no compelling scientific evidence supporting propolis's effectiveness.

Safety concerns and prior FDA enforcement

The class action lawsuit refers to studies documenting heavy metals in commercial propolis products, including lead, arsenic and cadmium, as well as pesticide residues. The presence of such contaminants in a product marketed for toddlers makes the company's silence on those risks significant, the lawsuit claims.

Attorneys also point to prior FDA warning letters issued to Natural Ginger and Herbal Vitality for making comparable drug-type claims on cough syrups, claiming regulators already flagged this kind of marketing in the natural remedy industry.

The legal claims

The complaint brings five causes of action under California law:

  • California's Unfair Competition Law, unlawful prong, for selling an unapproved drug
  • California's Unfair Competition Law, fraudulent prong, for misleading health claims
  • California's Unfair Competition Law, unfair prong, for conduct that harms consumers who cannot independently verify the claims
  • California's False Advertising Law, for untrue or misleading product statements
  • Consumer Legal Remedies Act, for misrepresenting the product's characteristics, benefits and quality

The plaintiff seeks at least $5 million in class restitution, punitive damages, disgorgement of profits, corrective advertising and destruction of existing products and labeling the complaint characterizes as unlawful.

What this means for consumers who bought the product

This is a newly filed lawsuit. There is no settlement, no claims process and no money available at this stage. Consumers who purchased the product during the proposed class period do not need to take any action at this time.